Next Article in Journal
Cardiotoxicity of Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia Therapy
Previous Article in Journal
Aurora Kinase Inhibitors: Which Role in the Treatment of Chronic Myelogenous Leukemia Patients Resistant to Imatinib?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Hematology Reviews
Volume 1
Issue 1
10.4081/hr.2009.e3
hematolrev-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite thumb_up
...
Endorse textsms
...
Comment
Hematology Reviews (renamed as Hematology Reports here since 2010) is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Tuberculosis Associated Thrombocytopenic Purpura: Effectiveness of Antituberculous Therapy

by
Raphael Borie
1,2,3,*,
Claire Fieschi
2,
Eric Oksenhendler
2 and
Lionel Galicier
2
1
Department of Pneumology A, Hospital Bichat, Assistance Publique, Hôpitaux de Paris, 75018 Paris, France
2
Department of Clinical Immunology, Hospital St Louis, Assistance Publique, Hôpitaux de Paris, 75010 Paris, France
3
Service de Pneumologie A, Hopital Bichat, 46 rue Henri Huchard, CEDEX 18, 75877 Paris, France
*
Author to whom correspondence should be addressed.
Hematol. Rev. 2009, 1(1), e3; https://doi.org/10.4081/hr.2009.e3 (registering DOI)
Submission received: 14 January 2009 / Revised: 25 February 2009 / Accepted: 9 March 2009 / Published: 10 March 2009

Abstract

Association of immune thrombocytopenic purpura and tuberculosis is a rare condition. In 5 patients presenting with this association, anti-tuberculous therapy was effective on both tuberculosis and thrombocytopenia suggesting a causal relationship between tuberculosis and immune thrombocytopenic purpura.
Keywords: immune thrombocytopenic purpura; immune; peripheral; thrombocytopenia immune thrombocytopenic purpura; immune; peripheral; thrombocytopenia

Share and Cite

MDPI and ACS Style

Borie, R.; Fieschi, C.; Oksenhendler, E.; Galicier, L. Tuberculosis Associated Thrombocytopenic Purpura: Effectiveness of Antituberculous Therapy. Hematol. Rev. 2009, 1, e3. https://doi.org/10.4081/hr.2009.e3

AMA Style

Borie R, Fieschi C, Oksenhendler E, Galicier L. Tuberculosis Associated Thrombocytopenic Purpura: Effectiveness of Antituberculous Therapy. Hematology Reviews. 2009; 1(1):e3. https://doi.org/10.4081/hr.2009.e3

Chicago/Turabian Style

Borie, Raphael, Claire Fieschi, Eric Oksenhendler, and Lionel Galicier. 2009. "Tuberculosis Associated Thrombocytopenic Purpura: Effectiveness of Antituberculous Therapy" Hematology Reviews 1, no. 1: e3. https://doi.org/10.4081/hr.2009.e3

APA Style

Borie, R., Fieschi, C., Oksenhendler, E., & Galicier, L. (2009). Tuberculosis Associated Thrombocytopenic Purpura: Effectiveness of Antituberculous Therapy. Hematology Reviews, 1(1), e3. https://doi.org/10.4081/hr.2009.e3

Article Metrics

Back to TopTop